UBS Maintains Buy on American Healthcare REIT, Raises Price Target to $63

Benzinga Newsdesk www.benzinga.com Positive 78.7%

Neg 0% Neu 0% Pos 78.7%

UBS analyst Michael Goldsmith maintains American Healthcare REIT (NYSE:AHR) with a Buy and raises the price target from $60 to $63.